Cross-fund · 5 holders
LYEL
LYELL IMMUNOPHARMA INC
CUSIP 55083R203
5
Tracked holders
$46.8M
Aggregate value
1,891,909
Shares
5
Active funds
Funds holding LYEL
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $25.4M | — | +47,426 | +6.1% |
| Millennium | Multi-Strategy | Q1 2026 | $9.2M | — | +400,254 | +682.4% |
| Citadel | Multi-Strategy | Q1 2026 | $7.9M | — | +52,761 | +15.5% |
| BlackRock | Institutional | Q1 2026 | $3.8M | — | +9,983 | +5.5% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $427,118 | — | +9,812 | +85.5% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.